| P2093 | author name string | Bruno Pradines | |
| | Joel Mosnier | |
| | Rémy Amalvict | |
| | French National Reference Centre for Imported Malaria Study Group | |
| | Nicolas Benoit | |
| | Raymond Bercion | |
| | Bécaye Fall | |
| | Marylin Madamet | |
| | Silman Diawara | |
| | Marie Gladys Robert | |
| | Mathieu Gendrot | |
| | Francis Tsombeng Foguim | |
| | Mamadou Wagué Gueye | |
| P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
| | Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 |
| | A molecular marker of artemisinin-resistant Plasmodium falciparum malaria | Q22061872 |
| | The 'permeome' of the malaria parasite: an overview of the membrane transport proteins of Plasmodium falciparum | Q24797363 |
| | Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study | Q27861941 |
| | UDP-galactose and acetyl-CoA transporters as Plasmodium multidrug resistance genes | Q27861953 |
| | Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery | Q27861956 |
| | Comprehensive characterization of genes required for protein folding in the endoplasmic reticulum | Q27937991 |
| | Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance | Q29615118 |
| | Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number | Q29615128 |
| | Mutations in the Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance | Q30047024 |
| | A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. | Q30379780 |
| | Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria | Q33435505 |
| | Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia | Q33668137 |
| | KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission | Q34057433 |
| | Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs | Q34541163 |
| | Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT. | Q34563560 |
| | Artemisinin-based combination treatment of falciparum malaria. | Q34731529 |
| | Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and Uíge Provinces, angola | Q34922694 |
| | Multinormal in vitro distribution of Plasmodium falciparum susceptibility to piperaquine and pyronaridine | Q35068138 |
| | Plasmodium falciparum susceptibility to standard and potential anti-malarial drugs in Dakar, Senegal, during the 2013-2014 malaria season | Q35101288 |
| | Reduced in vitro susceptibility to artemisinin derivatives associated with multi-resistance in a traveller returning from South-East Asia | Q35257668 |
| | Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay | Q35757486 |
| | Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations | Q35875707 |
| | Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa | Q36439747 |
| | Pfhrp2 and pfhrp3 polymorphisms in Plasmodium falciparum isolates from Dakar, Senegal: impact on rapid malaria diagnostic tests | Q36608430 |
| | Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study | Q36689509 |
| | Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014. | Q36884930 |
| | Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. | Q36919648 |
| | Prevalence of anti-malarial resistance genes in Dakar, Senegal from 2013 to 2014. | Q37077079 |
| | Intermittent Preventive Treatment with Dihydroartemisinin-Piperaquine in Ugandan Schoolchildren Selects for Plasmodium falciparum Transporter Polymorphisms That Modify Drug Sensitivity | Q37287899 |
| | Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes | Q37414137 |
| | Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam | Q37586458 |
| | A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study | Q37607320 |
| | Efficacy of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. | Q37623024 |
| | pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom | Q37669829 |
| | Confirmation of Plasmodium falciparum in vitro resistance to monodesethylamodiaquine and chloroquine in Dakar, Senegal, in 2015. | Q37708245 |
| | Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam | Q37722332 |
| | Structural Biology of the Major Facilitator Superfamily Transporters | Q38534222 |
| | West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia | Q38973256 |
| | In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron | Q39477444 |
| | Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study | Q39483732 |
| | Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas | Q39757934 |
| | Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates. | Q39762005 |
| | Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia | Q40064790 |
| | Reliability of antimalarial sensitivity tests depends on drug mechanisms of action. | Q40344256 |
| | pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum | Q41911870 |
| | Changing antimalarial drug sensitivities in Uganda | Q41911931 |
| | Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. | Q41921907 |
| | Impact of intermittent preventive treatment during pregnancy on Plasmodium falciparum drug resistance-mediating polymorphisms in Uganda | Q41992238 |
| | Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal | Q47992892 |
| | Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine | Q56342194 |
| | Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa | Q57789692 |
| | Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania | Q58546525 |
| | Mutations in actin-binding protein coronin confer reduced artemisinin susceptibility | Q61717127 |
| | Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal | Q91726552 |
| P433 | issue | 1 | |
| P921 | main subject | malaria | Q12156 |
| | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 293 | |
| P577 | publication date | 2019-08-28 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Low polymorphisms in pfact, pfugt and pfcarl genes in African Plasmodium falciparum isolates and absence of association with susceptibility to common anti-malarial drugs | |
| P478 | volume | 18 | |